Precision BioSciences, Inc.
DTIL
$6.30
$0.6311.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.26M | 698.00K | 1.26M | 51.14M | 68.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.26M | 698.00K | 1.26M | 51.14M | 68.70M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 34.26M | 698.00K | 1.26M | 51.14M | 68.70M |
| SG&A Expenses | 34.51M | 34.48M | 35.98M | 35.39M | 35.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 86.41M | 90.20M | 91.37M | 95.23M | 94.86M |
| Operating Income | -52.15M | -89.50M | -90.11M | -44.09M | -26.16M |
| Income Before Tax | -46.61M | -83.60M | -78.26M | -21.99M | 7.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -46.61 | -83.60 | -78.26 | -21.99 | 7.17 |
| Earnings from Discontinued Operations | 885.00K | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.72M | -83.60M | -78.26M | -21.99M | 7.17M |
| EBIT | -52.15M | -89.50M | -90.11M | -44.09M | -26.16M |
| EBITDA | -50.68M | -87.93M | -88.17M | -41.43M | -22.76M |
| EPS Basic | -5.13 | -8.40 | -8.81 | -1.98 | 1.93 |
| Normalized Basic EPS | -3.22 | -5.19 | -5.49 | -1.21 | 1.29 |
| EPS Diluted | -5.14 | -8.41 | -8.82 | -2.02 | 1.89 |
| Normalized Diluted EPS | -3.23 | -5.19 | -5.49 | -1.23 | 1.27 |
| Average Basic Shares Outstanding | 51.21M | 40.16M | 35.63M | 31.55M | 27.31M |
| Average Diluted Shares Outstanding | 51.33M | 40.16M | 35.63M | 31.59M | 27.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |